Bone BiologicsBBLG
Market Cap: $3.73M
About: Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Employees: 2
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
25% more funds holding
Funds holding: 4 [Q1] → 5 (+1) [Q2]
0.46% more ownership
Funds ownership: 4.76% [Q1] → 5.22% (+0.46%) [Q2]
22% less capital invested
Capital invested by funds: $89.1K [Q1] → $69.7K (-$19.5K) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for BBLG.